Efficacy of phospholipid-bound omega-3 versus standard omega-3 in patients with hypertriglyceridemia: a randomized clinical trial.

BMC Complement Med Ther · 2026 · PMC12882287 · PMID 41514392

Europe PMC DOI

hedged sentences

0.1620

closest p · 3.2× alpha

0.1620

boldest claim

The sentences

did not reach statistical significancep = 0.162not close (p > 0.1)

Although Fisher’s exact test did not reach statistical significance at this threshold (OR = 3.62; p = 0.162), a one-tailed Z-test for proportions confirmed a statistically significant difference (z = 1.74, p = 0.041).

also in 75,281 other papers

a favorable trendno p-value reported

These subgroup-specific analyses support a favorable trend in biomarker responses for the PL omega-3 formulation, particularly in individuals with elevated baseline TG or lower initial O3I.

also in 993 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.